{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:14:48Z","timestamp":1761128088238,"version":"build-2065373602"},"reference-count":53,"publisher":"Wiley","issue":"1P2","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3668,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p>Community\u2010acquired pneumonia (CAP) constitutes a major cause of morbidity and mortality. Although <jats:italic>Streptococcus pneumoniae<\/jats:italic> remains the bacterium most commonly implicated in CAP, the atypical respiratory pathogens <jats:italic>Mycoplasma pneumoniae, Legionella<\/jats:italic> species, and <jats:italic>Chlamydia pneumoniae<\/jats:italic> are being isolated with increasing frequency. Contrary to previous beliefs, these agents are capable of causing severe as well as mild\u2010to\u2010moderate illness. Moreover, they can affect all age groups. Indeed, atypical pathogens are implicated in up to 40% of CAP cases and commonly occur as copathogens in mixed\u2010infection CAP, an etiology associated with particularly high mortality (up to 25%). Laboratory methods for detecting atypical pathogens are slow, and there is significant overlap between atypical and typical CAP manifestations. For these reasons, accurate prediction of etiology cannot be made purely on clinical or radiologic grounds. Consequently, empiric antimicrobial therapy for atypical pathogens (with agents such as macrolides, fluoroquinolones, in some cases tetracyclines, or the new ketolides) warrants careful consideration and now is recommended for the treatment of CAP.<\/jats:p>","DOI":"10.1592\/phco.22.2.2s.33130","type":"journal-article","created":{"date-parts":[[2004,5,20]],"date-time":"2004-05-20T10:43:28Z","timestamp":1085049808000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Emerging Role of Atypical Pathogens in Community\u2010Acquired Pneumonia"],"prefix":"10.1002","volume":"22","author":[{"given":"Patrick P.","family":"Gleason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021315"},{"key":"e_1_2_1_3_2","first-page":"95","article-title":"Current estimates from the national health interview survey, 1994. National center for health statistics","volume":"10","author":"Adams P.F.","year":"1995","journal-title":"Vital Health Stat"},{"key":"e_1_2_1_4_2","first-page":"6","article-title":"1993 Summary: national hospital discharge survey","volume":"121","author":"Graves E.J.","year":"1995","journal-title":"Vital Health Stat"},{"key":"e_1_2_1_5_2","first-page":"556","article-title":"Premature deaths, monthly mortality and monthly physician contacts: United States","volume":"46","author":"Centers for Disease Control and Prevention.","year":"1997","journal-title":"MMWR"},{"key":"e_1_2_1_6_2","first-page":"1","article-title":"1994 Summary: national hospital discharge survey","volume":"278","author":"Graves E.J.","year":"1996","journal-title":"Adv Data"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1995.7.4.263"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440360129015"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00255-0"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.179"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/AAC.40.5.1175","article-title":"Ofloxacin versus standard therapy in treatment of community\u2010acquired pneumonia requiring hospitalization","volume":"40","author":"Plouffe J.F.","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/313965"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0891-5520(20)30407-4","article-title":"Atypical pneumonia","volume":"5","author":"Martin R.E.","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1938.02790520033007"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(05)70230-6"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.79.6.649"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196607212750303"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1961.03040030037007"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03110110083019"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0301.970103"},{"key":"e_1_2_1_21_2","unstructured":"Centers for Disease Control and Prevention.Mycoplasma pneumoniae technical information 1999. Available fromhttp:www.cdc.govncidoddbmddiseaseinfomycoplasmapneum_t.htm. Accessed October 26 2001."},{"issue":"1","key":"e_1_2_1_22_2","first-page":"S32","article-title":"Clinical overview of typical Mycoplasma pneumoniae infections","volume":"17","author":"Clyde W.A.","year":"1993","journal-title":"Clin Infect Dis"},{"key":"e_1_2_1_23_2","first-page":"227","article-title":"Outbreak of community\u2010acquired pneumonia caused by Mycoplasma pneumoniae: Colorado, 2000","volume":"50","author":"Centers for Disease Control and Prevention.","year":"2001","journal-title":"MMWR"},{"key":"e_1_2_1_24_2","first-page":"172","article-title":"Severe Mycoplasma disease: rare or underdiagnosed?","volume":"162","author":"Cassell G.H.","year":"1995","journal-title":"West J Med"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/319981"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.4.1007"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaire's' disease: risk factors for morbidity and mortality","volume":"154","author":"Marston B.J.","year":"1994","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/313954"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00624-0"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1274"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1330"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.6.958"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community\u2010acquired pneumonia: a meta\u2010analysis","volume":"275","author":"Fine M.J.","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, randomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in treatment of adults with community\u2010acquired pneumonia","volume":"41","author":"File T.M.","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1195"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.10.1010"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.4.296"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200103000-00001"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/319746"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050400"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1201"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.4.499"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000196557"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01713313"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.185"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(97)80008-4"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1997.11718562"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.10.1399"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02425150"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.1999.0775"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19174"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.21.2562"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.2.18S.33131"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3104-3108.2001"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.22.2.2S.33130","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.22.2.2S.33130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:01:52Z","timestamp":1761044512000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.22.2.2S.33130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":53,"journal-issue":{"issue":"1P2","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1592\/phco.22.2.2S.33130"],"URL":"https:\/\/doi.org\/10.1592\/phco.22.2.2s.33130","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}